Cite
HARVARD Citation
Yamamoto, Y. et al. (2020). Prognostic value of risk stratification using blood parameters for nivolumab in Japanese patients with metastatic renal-cell carcinoma. Japanese journal of clinical oncology. pp. 214-220. [Online].